286 related articles for article (PubMed ID: 35053291)
1. β-Synuclein: An Enigmatic Protein with Diverse Functionality.
Hayashi J; Carver JA
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053291
[TBL] [Abstract][Full Text] [Related]
2. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein.
Sekigawa A; Fujita M; Sekiyama K; Takamatsu Y; Hatano T; Rockenstein E; La Spada AR; Masliah E; Hashimoto M
Mol Brain; 2012 Sep; 5():34. PubMed ID: 23013868
[TBL] [Abstract][Full Text] [Related]
3. The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
Janowska MK; Baum J
Protein Sci; 2016 Jan; 25(1):286-94. PubMed ID: 26332674
[TBL] [Abstract][Full Text] [Related]
4. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Fujita M; Ho G; Takamatsu Y; Wada R; Ikeda K; Hashimoto M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325870
[TBL] [Abstract][Full Text] [Related]
5. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity.
Kim TE; Newman AJ; Imberdis T; Brontesi L; Tripathi A; Ramalingam N; Fanning S; Selkoe D; Dettmer U
Hum Mol Genet; 2021 Nov; 30(23):2332-2346. PubMed ID: 34254125
[TBL] [Abstract][Full Text] [Related]
6. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
[TBL] [Abstract][Full Text] [Related]
7. Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies.
Sekigawa A; Takamatsu Y; Sekiyama K; Hashimoto M
Biomolecules; 2015 May; 5(2):1000-11. PubMed ID: 25996784
[TBL] [Abstract][Full Text] [Related]
8. Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein.
Israeli E; Sharon R
J Neurochem; 2009 Jan; 108(2):465-74. PubMed ID: 19012742
[TBL] [Abstract][Full Text] [Related]
9. A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.
Moriarty GM; Olson MP; Atieh TB; Janowska MK; Khare SD; Baum J
J Biol Chem; 2017 Sep; 292(39):16368-16379. PubMed ID: 28710275
[TBL] [Abstract][Full Text] [Related]
10. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
[TBL] [Abstract][Full Text] [Related]
11. Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathies.
Fujita M; Sekigawa A; Sekiyama K; Takamatsu Y; Hashimoto M
Int J Mol Sci; 2012; 13(9):11584-11592. PubMed ID: 23109872
[TBL] [Abstract][Full Text] [Related]
12. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
Janowska MK; Wu KP; Baum J
Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
[TBL] [Abstract][Full Text] [Related]
13. Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation.
Sanjeev A; Sahu RK; Mattaparthi VSK
J Biomol Struct Dyn; 2017 Nov; 35(15):3342-3353. PubMed ID: 27809690
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
[TBL] [Abstract][Full Text] [Related]
15. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
Galvin JE; Uryu K; Lee VM; Trojanowski JQ
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13450-5. PubMed ID: 10557341
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
17. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
[TBL] [Abstract][Full Text] [Related]
18. Differences in the binding of copper(I) to α- and β-synuclein.
De Ricco R; Valensin D; Dell'Acqua S; Casella L; Gaggelli E; Valensin G; Bubacco L; Mangani S
Inorg Chem; 2015 Jan; 54(1):265-72. PubMed ID: 25495902
[TBL] [Abstract][Full Text] [Related]
19. A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain.
Fujita M; Sugama S; Sekiyama K; Sekigawa A; Tsukui T; Nakai M; Waragai M; Takenouchi T; Takamatsu Y; Wei J; Rockenstein E; Laspada AR; Masliah E; Inoue S; Hashimoto M
Nat Commun; 2010 Nov; 1():110. PubMed ID: 21045828
[TBL] [Abstract][Full Text] [Related]
20. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons.
Ramalingam N; Dettmer U
J Biol Chem; 2021; 296():100271. PubMed ID: 33428933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
